Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Edgewise Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +13 vs. Q4 2023
- Shares held
- 91.6M
- +12.0M (+15.0%) vs. Q4 2023
- Total value
- $1.67B
- +$799.6M (+91.8%) vs. Q4 2023
- New holders
- 32
- 60 more added
- Sold out
- 19
- 28 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 499,520 | $9.11M | 0.00% | +136,277+37.5% | Added |
| Millennium Management LLC | 532,255 | $9.71M | 0.01% | +400,900+305.2% | Added |
| American Century Companies Inc | 559,334 | $10.2M | 0.01% | −211,118−27.4% | Reduced |
| Granahan Investment Management Inc | 608,012 | $11.1M | 0.39% | −466,896−43.4% | Reduced |
| Parkman Healthcare Partners LLC | 653,653 | $11.9M | 1.46% | +2,028+0.3% | Added |
| Opaleye Management Inc. | 665,000 | $12.1M | 2.64% | −34,000−4.9% | Reduced |
| Artal Group S.A. | 811,718 | $14.8M | 0.38% | +811,718 | New |
| State Street Corp | 1,211,476 | $22.1M | 0.00% | +318,767+35.7% | Added |
| EcoR1 Capital, LLC | 1,250,385 | $22.8M | 0.58% | −2,242,809−64.2% | Reduced |
| Driehaus Capital Management LLC | 1,267,819 | $23.1M | 0.23% | +872,750+220.9% | Added |
| Geode Capital Management, LLC | 1,369,897 | $25.0M | 0.00% | +422,851+44.6% | Added |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $28.3M | 24.80% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,747,844 | $31.9M | 0.01% | +865,948+98.2% | Added |
| Janus Henderson Group PLC | 1,805,312 | $32.9M | 0.02% | +590,299+48.6% | Added |
| VR Adviser, LLC | 1,818,182 | $33.2M | 1.58% | +1,818,182 | New |
| TCG Crossover Management, LLC | 2,272,728 | $41.5M | 3.28% | +2,272,728 | New |
| Perceptive Advisors LLC | 2,319,646 | $42.3M | 0.75% | +1,764,091+317.5% | Added |
| Paradigm Biocapital Advisors LP | 2,446,373 | $44.6M | 1.57% | +2,446,373 | New |
| Citadel Advisors LLC | 2,719,291 | $49.6M | 0.05% | +133,361+5.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,874,586 | $52.4M | 0.91% | −1,058,551−26.9% | Reduced |
| Cormorant Asset Management, LP | 3,006,534 | $54.8M | 2.42% | +454,545+17.8% | Added |
| Frazier Life Sciences Management, L.P. | 3,303,567 | $60.3M | 2.54% | +636,364+23.9% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,339,146 | $60.9M | 0.23% | −2,820,000−45.8% | Reduced |
| Vanguard Group Inc | 4,017,433 | $73.3M | 0.00% | +1,892,053+89.0% | Added |
| BlackRock Inc. | 5,167,006 | $94.2M | 0.00% | +1,859,896+56.2% | Added |
| Baker Bros. Advisors LP | 5,840,059 | $106.5M | 1.34% | +2,727,273+87.6% | Added |
| FMR LLC | 6,365,724 | $116.1M | 0.01% | −126,789−2.0% | Reduced |
| Ra Capital Management, L.P. | 8,909,091 | $162.5M | 2.07% | +8,909,091 | New |
| OrbiMed Advisors LLC | 15,021,721 | $274.0M | 5.37% | +454,545+3.1% | Added |
| Novo Holdings A/S | 0 | $0 | 0.00% | −6,071,703−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −2,537,176−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −1,187,880−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −950,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −501,256−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −327,801−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −327,801−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −270,000−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −150,418−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −98,449−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −72,117−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −61,384−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −47,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −38,788−100.0% | Sold out |
| Checkpoint Capital L.P. | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,037−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |